1. Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma
   Sadegh Safaei et al, 2022, Cancer Biomarkers CrossRef
2. Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study
   Haijun Zheng et al, 2022, BMC Cardiovascular Disorders CrossRef
3. Mitochondrial dysregulation is a key regulator of gastric cancer subtype carcinogenesis
   Karthik Balakrishnan, 2024, Genome Instability & Disease CrossRef
4. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma
   Tzu-Ching Chang et al, 2022, International Journal of Molecular Sciences CrossRef
5. The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
   Gaofeng Li et al, 2022, Frontiers in Oncology CrossRef
6. The role of mitochondrial dynamics in the pathophysiology of endometriosis
   Hiroshi Kobayashi et al, 2023, Journal of Obstetrics and Gynaecology Research CrossRef
7. Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor
   Valentin Baumgartner et al, 2024, International Journal of Molecular Sciences CrossRef
8. The Epithelial and Stromal Immune Microenvironment in Gastric Cancer: A Comprehensive Analysis Reveals Prognostic Factors with Digital Cytometry
   Wenjun Shen et al, 2021, Cancers CrossRef
9. Centromere protein U (CENPU) promotes gastric cancer cell proliferation and glycolysis by regulating high mobility group box 2 (HMGB2)
   Taozhi Deng et al, 2021, Bioengineered CrossRef
10. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer
    Hang Yang et al, 2021, Inflammation Research CrossRef